December 23, 2008 — In the treatment of advanced ovarian cancer, neoadjuvant chemotherapy before surgical debulking may be the new standard of care — especially in countries where the scheduling of a ...

Significant disparities exist in the adoption of minimally invasive interval debulking surgery for advanced ovarian cancer, with gaps potentially widening as the procedure becomes more common.

CHICAGO -- Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve progression-free survival (PFS) for the first time in a phase ...

For patients with high-grade serous ovarian cancer, an aggressive form of the disease, surgery to remove the tumor before starting chemotherapy should lead to better outcomes than the reverse, ...

In an interview with CURE, Dr. Susana Campos, clinical director of the Division of Gynecologic Oncology and assistant professor of medicine at Harvard Medical School, discussed re ...

FIGO (International Federation of Gynecology and Obstetrics) stage is important in finding the best treatment for patients with epithelial ovarian cancer, particularly when considering primary ...

Comprehensive Genomic Profiling for Resectable Pancreatic Cancer: The Earlier the Better? Data from CHIVA randomized phase II trial (ClinicalTrials.gov identifier: NCT01583322) and Policlinico Gemelli ...

Fuzuloparib monotherapy significantly improved PFS in advanced ovarian cancer, but adding apatinib did not enhance outcomes. The study included patients with newly diagnosed ovarian, fallopian tube, ...

Ovarian cancer lacks effective screening, making early detection difficult; symptoms are often non-specific and include bloating, early satiety, and abdominal pain. Diagnosis involves imaging, biopsy, ...